AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site
Seattle, Aug. 02, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the strategic development and operational excellence in clinical and commercial biologics production at its Seattle, Washington site. Effective August 2, 2021, Kevin Ingham will